# Title
Serdar Balcı

![](img%5CGastrointestinal-and-Pancreas-Neuroendocrine-Tumors0.jpg)

# Gastrointestinal and Pancreas Neuroendocrine Tumors

# Serdar BALCI, MD

# GASTROINTESTINAL NEUROENDOCRINE TUMORS

# Carcinoid

**Dr. Oberndorfer**

**Learn his life and his contribution to “Istanbul” and “Karzinoide”**

![](img%5CGastrointestinal-and-Pancreas-Neuroendocrine-Tumors1.png)

# Carcinoid vs Neuroendocrine Tumor

- **Carcinoid is now only used in lung tumors**
- **In GIS and pancreas**
  - **Well Differentiated Neuroendocrine Tumor (NET)**

# Well Differentiated Neuroendocrine Tumor

- **Most in GI Tract**
  - **40% in small intestine**
- **Tracheobroncial tree, lungs**

![](img%5CGastrointestinal-and-Pancreas-Neuroendocrine-Tumors2.png)

# Neuroendocrine Tumors

- **May be associated with**
  - **Endocrine cell hyperplasia**
  - **Chronic atrophic gastritis**
  - **Zollinger-Ellison syndrome**
- **Grade**
  - **based on mitotic activity**
  - **fraction of cells immunohistochemcially positive for Ki67, a
    mitotic marker**
- **Localization, extent and presence of atrophy and intestinal
  metaplasia are important prognostically**
- **High-grade neuroendocrine tumors**
  - **neuroendocrine carcinoma**

# Neuroendocrine Neoplasms

- **Hyperplasia**
  - **In the setting of chronic gastritis**
- **\<0.5 cm microNET, microadenoma**
- **Well differentiated NET**
  - **Grade**
    - **Mitotic activity**
    - **Ki-67 index**
  - **G1, G2, G3**
- **Small cell carcinoma, Large cell carcinoma**

# Grade

![](img%5CGastrointestinal-and-Pancreas-Neuroendocrine-Tumors3.png)

**Endocr Pathol. 2014 Mar;25(1):65-79**

![](img%5CGastrointestinal-and-Pancreas-Neuroendocrine-Tumors4.png)

# Neuroendocrine Tumor

**intramural or submucosal masses**

**small polypoid lesions**

**yellow or tan in appearance**

**form intense desmoplastic reaction that may cause kinking of the bowel
and obstruction**

**Robbins Basic Pathology**

![](img%5CGastrointestinal-and-Pancreas-Neuroendocrine-Tumors5.png)

**Neuroendocrine Tumor**

**islands, trabeculae, strands, glands, or sheets of uniform cells**

**Robbins Basic Pathology**

![](img%5CGastrointestinal-and-Pancreas-Neuroendocrine-Tumors6.png)

![](img%5CGastrointestinal-and-Pancreas-Neuroendocrine-Tumors7.png)

![](img%5CGastrointestinal-and-Pancreas-Neuroendocrine-Tumors8.png)

![](img%5CGastrointestinal-and-Pancreas-Neuroendocrine-Tumors9.png)

**Neuroendocrine Tumor**

**scant, pink granular cytoplasm**

**round to oval stippled nucleus**

**salt and pepper chromatin**

**Robbins Basic Pathology**

![](img%5CGastrointestinal-and-Pancreas-Neuroendocrine-Tumors10.png)

# Cytology

**Endocr Pathol. 2014 Mar;25(1):65-79**

![](img%5CGastrointestinal-and-Pancreas-Neuroendocrine-Tumors11.png)

![](img%5CGastrointestinal-and-Pancreas-Neuroendocrine-Tumors12.png)

![](img%5CGastrointestinal-and-Pancreas-Neuroendocrine-Tumors13.png)

![](img%5CGastrointestinal-and-Pancreas-Neuroendocrine-Tumors14.png)

# Clinical Features of GI NET

**Peak incidence in the sixth decade, may appear at any age**

**Symptoms by the hormones produced**

# Zollinger-Ellison syndrome

**NET produce gastrin**

**Gastrinomas of small intestine or pancreas**

**Increase oxyntic mucosa, increased acid production**

**Ulcer formation in stomach**

# Carcinoid syndrome

**Ileal tumors**

**Cutaneous flushing, sweating, bronchospasm, colicky abdominal pain,
diarrhea, and right-sided cardiac valvular fibrosis**

**If confined to intestine, the secretions are metabolised in liver**

**If large tumor, in nonportal circulation, metastasis to liver →
carcinoid syndrome**

# Location is important for prognosis

- **Foregut**
  - **Stomach, duodenum proximal to the ligament of Treitz, and
    esophagus**
  - **Rarely metastasize, generally cured by resection**
  - **Gastric NET without predisposing factors (atrophic gastritis) are
    often more aggressive**

![](img%5CGastrointestinal-and-Pancreas-Neuroendocrine-Tumors15.png)

- **Midgut**
  - **jejunum and ileum**
  - **Often multiple**
  - **Tend to be aggressive**
  - **Greater depth of local invasion, increased size, and the presence
    of necrosis and mitoses are associated with a worse outcome**
- **Hindgut**
- **Appendix and colorectum**
- **Discovered incidentally**
- **Appendix**
  - **occur at any age**
  - **Generally located at the tip**
  - **Rarely more than 2 cm in diameter and are almost always benign**
- **Rectal**
  - **Produce polypeptide hormones**
  - **Abdominal pain and weight loss**
  - **Discovered when small, metastasis is uncommon**

# PANCREATIC NEUROENDOCRINE TUMORS

![](img%5CGastrointestinal-and-Pancreas-Neuroendocrine-Tumors16.png)

# Pancreatic Neuroendocrine Tumors

- **Islet cell tumors**
- **2% of all pancreatic neoplasms**
- **Most common in adults**
- **Single or multifocal**
- **Liver is the most common site of organ metastases**
- **Produce and secrete pancreatic hormones, but some are
  nonfunctional**
- **Nonfunctional are larger lesions at diagnosis**
  - **no symptoms related to excessive hormone production**

![](img%5CGastrointestinal-and-Pancreas-Neuroendocrine-Tumors17.png)

**Autopsy Pathology: A Manual and Atlas**

![](img%5CGastrointestinal-and-Pancreas-Neuroendocrine-Tumors18.png)

**Endocr Pathol. 2014 Mar;25(1):65-79**

![](img%5CGastrointestinal-and-Pancreas-Neuroendocrine-Tumors19.jpg)

**Ankara Atatürk Eğitim ve Araştırma Hastanesi Arşivi**

![](img%5CGastrointestinal-and-Pancreas-Neuroendocrine-Tumors20.png)

**Endocr Pathol. 2014 Mar;25(1):65-79**

- **All PanNETs are regarded as having malignant potential**
- **Insulinomas are detected earlier and they are regarded as “benign”**
- **65-80% of PanNETs manifest with overtly malignant features of
  biologic aggressiveness**
  - **invasion into local tissues or distant metastases**
- **Grade**
  - **Mitosis**
  - **proliferation marker Ki-67**
- **Genetics:**
  - **Familial MEN syndrome, type 1**
    - **MEN1**
  - **Loss-of-function mutations in tumor suppressor genes**
    - **PTEN and TSC2**
      - **negative regulators of the oncogenic mammalian TOR (mTOR)
        signaling pathway**
  - **Inactivating mutations**
    - **ATRX and DAXX**

![](img%5CGastrointestinal-and-Pancreas-Neuroendocrine-Tumors21.png)

**Endocr Pathol. 2014 Mar;25(1):65-79**

# Insulinomas

- **Beta cell tumors **
- **Most common type of PanNET**
- **Whipple triad**
  - **Low blood glucose**
  - **Symptoms and signs of hypoglycemia**
  - **Resolve with blood glucose elevation**
- **Favorable biologic behavior**
  - **Possibly because the vast majority are identified while they are
    small**
    - **\<2 cm in diameter**
  - **localized to the pancreas**
- **Most are solitary lesions**
  - **multifocal tumors or tumors ectopic to the pancreas may be
    encountered**
- **Malignancy in insulinomas**
  - **\<10% of cases**
  - **Local invasion or metastases**

**Look remarkably like giant islets**

**Preservation of the regular cords of monotonous cells and their
orientation to the vasculature**

**Not even malignant lesions present much evidence of anaplasia, and
they may be deceptively encapsulated**

![](img%5CGastrointestinal-and-Pancreas-Neuroendocrine-Tumors22.png)

**Deposition of amyloid in the extracellular tissue is a characteristic
feature of many insulinomas**

**Robbins Basic Pathology**

![](img%5CGastrointestinal-and-Pancreas-Neuroendocrine-Tumors23.png)

**Under the electron microscope, neoplastic beta cells, like their
normal counterparts, display distinctive round granules**

**Robbins Basic Pathology**

# Gastrinomas

- **Marked hypersecretion of gastrin **
- **Likely to arise in the duodenum and peripancreatic soft tissues as
  in the pancreas**
  - **gastrinoma triangle**
- **Zollinger-Ellison syndrome**
  - **Pancreatic islet cell lesions with hypersecretion of gastric acid
    and severe peptic ulceration**
    - **90-95% of patients with gastrinomas**
  - **Duodenal and gastric ulcers often are multiple**
  - **Unusual locations such as the jejunum**
    - **intractable jejunal ulcers**
- **More than half of the affected patients have diarrhea**

**Over half of gastrin-producing tumors are locally invasive or have
already metastasized at the time of diagnosis**

**25% of patients, arise in conjunction with other endocrine tumors**

**MEN-1 associated gastrinomas frequently are multifocal**

**Sporadic gastrinomas usually are single**

**Histologically bland and rarely exhibit marked anaplasia**

# α-cell tumors (glucagonomas)

- **Increased serum levels of glucagon**
- **Mild diabetes mellitus**
- **A characteristic skin rash**
  - **Necrolytic migratory erythema**
- **Anemia**
- **Perimenopausal and postmenopausal women**

# δ-cell tumors (somatostatinomas)

**Associated with diabetes mellitus, cholelithiasis, steatorrhea, and
hypochlorhydria**

**Difficult to localize preoperatively**

**High plasma somatostatin levels are required for diagnosis**

# VIPoma

- **WDHA syndrome**
  - **Watery diarrhea, hypokalemia, achlorhydria**
- **Some are locally invasive and metastatic**
- **Associated neural crest tumors**
  - **neuroblastomas, ganglioneuroblastoma, ganglioneuromas,
    pheochromocytomas**

# Rare pancreas NET

**Serotonin and an atypical carcinoid syndrome are exceedingly rare**

**Pancreatic polypeptide-secreting endocrine tumors present as mass
lesions as even high plasma levels of this hormone fail to cause
symptoms**

**Multihormonal tumors**

![](img%5CGastrointestinal-and-Pancreas-Neuroendocrine-Tumors24.png)

**Endocr Pathol. 2014 Mar;25(1):65-79**

![](img%5CGastrointestinal-and-Pancreas-Neuroendocrine-Tumors25.png)

**Endocr Pathol. 2014 Mar;25(1):65-79**

![](img%5CGastrointestinal-and-Pancreas-Neuroendocrine-Tumors26.png)

**Endocr Pathol. 2014 Mar;25(1):65-79**

![](img%5CGastrointestinal-and-Pancreas-Neuroendocrine-Tumors27.png)

**Endocr Pathol. 2014 Mar;25(1):65-79**

![](img%5CGastrointestinal-and-Pancreas-Neuroendocrine-Tumors28.png)

**Endocr Pathol. 2014 Mar;25(1):65-79**
